Life Sciences & Biotechnology
Research Agricultural
Total number of Record(s): 5525
Title | Principal Investigator | Start Year | Funding Agency | Focus Area |
---|---|---|---|---|
Target identification, pharmacokinetics & pharmacodynamics of a novel ant tuberculosis lead that is effective against MDR-TB | Dr. Z.A. Parry Principal Scientist CSIR-Indian Institute of Integrative Medicine Jammu & Kashmir | 2020 | Department of Bio-Technology (DBT) | Research & Development (R&D) |
Targeted delivery of human coagulation factor VII in myeloid compartment of haematopoietic stem cells for gene therapy of hemophilia B by Adenoassociated virus (AAV) vectors | Dr. Jayandharan Giridhara Rao, Associate Professor, Indian Institute of Technology (IIT), Kanpur | 2016 | Department of Biotechnology (DBT), Government of Inida | NA |
Targeted delivery of lysosoma lenzymeusing mannose-6 phosphate modifies nano carries for treatment of lysosomal storage diseases | Dr. S.S. Gupta, Indian Institute of Science, Bangalore, Karnataka Education & Research (Kolkata), West Bengal | 2019 | Department of Science and Technology, (DST) | Nano-Mission, N-M |
Targeted delivery of therapeutics to pancreatic beta cells by nanocarriers to augment glucose-dependent insulin secretion | Dr. Prosenjit Mondal Associate Professor, School of Basic Sciences, Indian Institute of Technology (IIT) Mandi, Himachal Pradesh | 2015 | Department of Science and Technology (DST) | Herapeutics to pancreatic beta cells |
Targeted drug delivery using gold nonocarrier with special application to prostate cancer | Dr. Ravi Shankaran Dhesingh, Associate Professor, University of Madras (UNOM), Chennai | 2015 | Department of Biotechnology (DBT), Government of Inida | NA |
Targeted identification and molecular characterization of important flowering gene homologs in a rarely flowering tree Bambusa tulda | Dr. Malay Das, Assistant Professor, Presidency University (PU), Kolkata | 2015 | Department of Biotechnology (DBT), Govt. of Inida, New Delhi | Study on Bambusa tulda |
Targeted nano-immunochemotherapeutic for improved triple-negative breast cancer therapy | Ms. Nagma Banjare, CSIR-Indian Institute Of Integrative Medicine, Jammu, Jammu And Kashmir (180001) | 2024 | Department of Science and Technology (DST) | Medical Sciences |
Targeted next generation sequencing (NGS) for evaluating PI3/AKT/mTOR pathway as a potential therapeutic target for triple negative breast cancer | Dr. Amanjit Bal, Professor, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Triple negative breast cancer |
Targeted, safe and effective delivery of doxorubicin to breast cancer by means of strategically-designed folatetagged phospholipid-based mixed nanomicelles | Dr. Kaisar Raza, Assistant Professor, Central University of Rajasthan (CURAJ), Rajasthan | 2017 | Department of Biotechnology (DBT), Government of Inida | NA |
Targeting Aurora Kinase in Colorectal Cancer Rational Drug Design and Validation | Dr. Rituraj Purohit, Senior Scientist, Biotechnology, Institute of Himalayan Bioresource Technology (IHBT), Palampur, Himachal Pradesh | 2017 | Science and Engineering Research Board (SERB), Department of Science & Technology (DST), Government of India | NA |